Catherine Marle

Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY.

Horama SA engages in the development of gene therapies, It focuses on ophthalmological diseases for preserving visual autonomy of patients. The company was founded by Denis Cayet, Christian Hamel, Guylene Le Meur, Philippe Moullier, Vasiliki Kalatzis, and Michel Weberin March 2014 and is headquartered in Paris, France.

Trophos SA engages in manufacturing and development of pharmaceutical products. It offers medicines to patients with conditions such as amyotrophic lateral sclerosis, spinal muscular atrophy and cardiac ischemia reperfusion injury. The company was founded by Antoine Beret and Michel Delaage in 1991 and is headquartered in Marseille, France.

LBP AM SA (LBP AM) is an asset manager headquartered in Paris, France. Formerly known as La Banque Postale Asset Management SA, the firm was founded in 1988 through the joint venture between Aegon Asset Management and La Banque Postale. LBP AM offers a complete, customized portfolio management solution and services for institutional investors.

Tocqueville Finance SA is the asset management subsidiary of La Banque Postale SA, which is owned by La Poste SA in France. Headquartered in Paris, the firm was founded in 1991 and offers tailor-made investment solutions to private individual and institutional clients.

AEW SA is a French real estate investment management company that has been in operation for over 40 years. The private company is based in Paris, FR, and has subsidiaries in the United Kingdom and Luxembourg. The company offers investment strategies to institutional investors and manage assets with discipline and attention to risk management. AEW is one of the largest real estate investment managers in the world, with over 800 clients and $91.60/€84.3 billion in assets under management across all property types in North America, Europe, and Asia Pacific. The CEO of the company is Robert William Ian Wilkinson.

Xyence Capital SGR (Xyence Capital) is a venture capital firm founded in 2002 by Stefano Peroncini and Pierluigi Paracchi. The firm is headquartered in Milano, Italy.

Lio Capital Srl engages in the provision of investment services. It specializes in special situations and distressed investments. Its activities include purchase of overdue credits from small and medium-sized enterprises (SMEs) operating in the Italian Public Administration sector, selection of distressed mortgage loans, and purchase of mortgage loans at a discount, but lower than the current market value of the collateral. The company was founded in 2012 and is headquartered in Milan, Italy.

Founded in 2010, Definitive Capital Management LP is a hedge fund manager located in Radnor, Pennsylvania. The firm manages the Definitive Guardian Fund Ltd. (formerly the Vision Guardian Fund Ltd.) and the Definitive Guardian Partners LP (formerly the Vision Guardian Partners LP).

RCI Banque SA engages in the provision of automobile financing services. The firm offers financing and service solutions for private customer, corporate, fleets and dealer networks. Its services also include refinancing, banking operations, and savings accounts. The company was founded in 1924 and is headquartered in Paris, France.

Direct Ferries Ltd. provides ferry ticketing service. The firm is a multi-platform impartial ferry ticketing service offering a way to look, compare, and book scheduled ferry crossings to virtually any ferry port in Europe. The company was founded by Howard John Davies in 1999 and is headquartered in London, the United Kingdom.

StoryCenter is a project that has developed a resource for families to use as they explore how best to support their trans and nonbinary young people in a divisive climate where laws banning gender-affirming care and appropriate health services for trans and nonbinary youth have been proposed and passed in numerous red states. The project aims to create supportive family and community environments where young people can explore and express their transness. Additionally, the Kennedy-Lugar Youth Exchange and Study (YES) program through the U.S. Department of State is established to foster human understanding and open, sustainable relationships across cultures by inviting high school students from countries with significant Muslim populations to live with a host family for an academic year.

Rocket Internet is the venture capital division of Rocket Internet SE founded in 2007 by the Samwer brothers Marc, Alexander, and Oliver. The firm is headquartered in Berlin, Germany.

Founded in 1985, Part of Bain & Co., Inc., Bain & Co., Inc. (London) is a British company that provides management consultancy services. The company is based in London, UK.

Caisse des Dépôts & Consignations engages in missions of public interest and operates on behalf of central, regional, and local governments in France. The firm serves as an investment manager for the government and oversees tax-exempt funds collected by savings banks. The company was founded in 1816 and is headquartered in Paris, France.

France Biotech Association is an independent association founded in 1997 that brings together healthtech entrepreneurs and their expert partners. The non-profit company is based in Paris, France. The association actively contributes to meeting the many challenges of the healthtech industry, such as companies' financing, innovation-related taxes, regulatory and market access related issues. It offers concrete competition and solutions through its commissions and working groups to help startups and SMEs become international leaders capable of rapidly developing and bringing innovative solutions to patients. The French company was founded by Philippe Pouletty, Pascal Brandys, Denis J. Lucquin.

Genzyme Genetics, Inc. provides laboratory testing and diagnostic services specifically for reproductive and oncology tests. It provides tests for cystic fibrosis carriers and cancers. The company is headquartered in Westborough, MA.

Tc Land Expression SA operates as a molecular diagnostic company. It focuses on the development and commercialisation of tests aimed at monitoring patients with immunological conditions. The firm specializes in the area of organ transplantation and immune mediated disorders. Its development programs encompass RA-INF-Dx, IMD Dx2, IMD Dx3, and L-TolX. The company was founded by Marina Guillet and Alain Huriez in November 2002 and is headquartered in Huningue, France.

Wellcome Trust Technology Transfer (Wellcome Trust Technology Transfer) is a venture capital subsidiary of The Wellcome Trust Ltd. founded in 1992 by Graham Eric Fagg. The firm is headquartered in London.

Acesion Pharma ApS develops drugs for the treatment of atrial fibrillation (AF), the most common type of cardiac arrhythmia. The firm's technology blocks ion channel with a selective drug molecule constitutes a target for developing treatment of AF. The company was founded by Ulrik Svane S?rensen and Morten Grunnet in 2011 and is headquartered in Copenhagen, Denmark.

Canbex Therapeutics Ltd. engages in the development of novel peripherally-acting cannabinoid agonists and mimetics for the treatment of multiple sclerosis spasticity and pain. Its lead drug candidate, VSN 16, has been established as a potent, stable and orally-available agonist of GPR-55 with a clear anti-spasticity effect in a validated preclinical model. The company was founded by David Baker, Gavin Giovannoni, Cristina Visintin, Gareth Pryce and David Lawrence Selwood in 2005 and is headquartered in London, the United Kingdom.

VarmX BV is a spin-off from Leiden University Medical Center (LUMC) founded in 2016 by Professor Pieter Reitsma, a world-leading expert in hemostasis and thrombosis. VarmX is based in Leiden, NL. The Dutch company's lead compound, VMX-C001, is a modified recombinant blood factor X developed for the treatment of severe spontaneous bleeding and for the prevention of bleeding during urgent surgery in patients taking oral factor Xa inhibitors (FXa DOACs) as anticoagulation therapy. The company is supported by a strong syndicate of investors. Jan K. Öhrström has been the CEO of the company since 2018.